Does RAVULIZUMAB Cause Drug ineffective? 5 Reports in FDA Database

Q: Does RAVULIZUMAB cause Drug ineffective?

5 reports of Drug ineffective have been filed with the FDA for RAVULIZUMAB, representing 4.2% of all RAVULIZUMAB adverse event reports.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Drug ineffective have been filed in association with RAVULIZUMAB (Ultomiris). This represents 4.2% of all adverse event reports for RAVULIZUMAB.

Reports of Drug ineffective with RAVULIZUMAB

4.2%

of all RAVULIZUMAB reports

Deaths

Hospitalizations

How Dangerous Is Drug ineffective From RAVULIZUMAB?

Of the 5 reports, 2 (40.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.

Is Drug ineffective Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RAVULIZUMAB. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does RAVULIZUMAB Cause?

Off label use (11) Pneumonia (8) Neuromyelitis optica spectrum disorder (5)

What Other Drugs Cause Drug ineffective?

ADALIMUMAB (71,926) METHOTREXATE (70,142) ETANERCEPT (60,367) ADAPALENE (52,181) ABATACEPT (35,212) INFLIXIMAB (33,738) TOCILIZUMAB (32,342) RITUXIMAB (32,186) LEFLUNOMIDE (31,396) HYDROXYCHLOROQUINE (31,057)

Which RAVULIZUMAB Alternatives Have Lower Drug ineffective Risk?

RAVULIZUMAB vs RAVULIZUMAB-CWVZ RAVULIZUMAB vs REBAMIPIDE RAVULIZUMAB vs REBETOL RAVULIZUMAB vs REBIF RAVULIZUMAB vs REBOXETINE

RAVULIZUMAB Full Profile All Drug ineffective Reports All Drugs Causing Drug ineffective RAVULIZUMAB Demographics